BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17503884)

  • 1. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials.
    Bavry AA; Mood GR; Kumbhani DJ; Borek PP; Askari AT; Bhatt DL
    Am J Cardiovasc Drugs; 2007; 7(2):135-41. PubMed ID: 17503884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit.
    Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM
    Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR; Leslie S; Stern T;
    JAMA; 2001 Apr; 285(13):1711-8. PubMed ID: 11277825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for acute coronary syndrome.
    Vale N; Nordmann AJ; Schwartz GG; de Lemos J; Colivicchi F; den Hartog F; Ostadal P; Macin SM; Liem AH; Mills E; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006870. PubMed ID: 21678362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
    Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials.
    Briel M; Schwartz GG; Thompson PL; de Lemos JA; Blazing MA; van Es GA; Kayikçioglu M; Arntz HR; den Hartog FR; Veeger NJ; Colivicchi F; Dupuis J; Okazaki S; Wright RS; Bucher HC; Nordmann AJ
    JAMA; 2006 May; 295(17):2046-56. PubMed ID: 16670413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction.
    Walter DH; Fichtlscherer S; Britten MB; Auch-Schwelk W; Schächinger V; Zeiher AM
    Am J Cardiol; 2002 Jan; 89(1):1-6. PubMed ID: 11779513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early statin initiation and outcomes in patients with acute coronary syndromes.
    Newby LK; Kristinsson A; Bhapkar MV; Aylward PE; Dimas AP; Klein WW; McGuire DK; Moliterno DJ; Verheugt FW; Weaver WD; Califf RM;
    JAMA; 2002 Jun; 287(23):3087-95. PubMed ID: 12069671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for acute coronary syndrome.
    Vale N; Nordmann AJ; Schwartz GG; de Lemos J; Colivicchi F; den Hartog F; Ostadal P; Macin SM; Liem AH; Mills EJ; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006870. PubMed ID: 25178118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
    Wiviott SD; de Lemos JA; Cannon CP; Blazing M; Murphy SA; McCabe CH; Califf R; Braunwald E
    Circulation; 2006 Mar; 113(11):1406-14. PubMed ID: 16534008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early initiation of treatment with statins in acute coronary syndromes.
    Olsson AG; Schwartz GG
    Ann Med; 2002; 34(1):37-41. PubMed ID: 12014432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
    Schwartz GG; Bessac L; Berdan LG; Bhatt DL; Bittner V; Diaz R; Goodman SG; Hanotin C; Harrington RA; Jukema JW; Mahaffey KW; Moryusef A; Pordy R; Roe MT; Rorick T; Sasiela WJ; Shirodaria C; Szarek M; Tamby JF; Tricoci P; White H; Zeiher A; Steg PG
    Am Heart J; 2014 Nov; 168(5):682-9. PubMed ID: 25440796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM;
    N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.
    Szarek M; Steg PG; DiCenso D; Bhatt DL; Bittner VA; Budaj A; Diaz R; Goodman SG; Gotcheva N; Jukema JW; Pordy R; Roe MT; Sourdille T; White HD; Xavier D; Zeiher AM; Schwartz GG
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005858. PubMed ID: 31707826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
    Marschner IC; Colquhoun D; Simes RJ; Glasziou P; Harris P; Singh BB; Friedlander D; White H; Thompson P; Tonkin A;
    J Am Coll Cardiol; 2001 Jul; 38(1):56-63. PubMed ID: 11451296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials.
    Bavry AA; Kumbhani DJ; Rassi AN; Bhatt DL; Askari AT
    J Am Coll Cardiol; 2006 Oct; 48(7):1319-25. PubMed ID: 17010789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.